It looks like you're new here. If you want to get involved, click one of these buttons!
https://bbc.com/news/world-asia-china-56713663Brazilian trials of the Sinovac vaccine CoronaVac for instance, showed an efficacy rate of around 50.4%, which is barely over the 50% threshold needed for regulatory approval by the World Health Organization (WHO).
© 2015 Mutual Fund Observer. All rights reserved.
© 2015 Mutual Fund Observer. All rights reserved. Powered by Vanilla
Comments